Verzenio 100 mg

VERZENIO 100 MG tablets contain abemaciclib, a medication used in cancer treatment. This oral tablet is manufactured by Eli Lilly Canada Inc. and is designed to support specific therapeutic needs.

VERZENIO 100 MG tablets are generally used in the management of certain types of cancer. Abemaciclib is a type of CDK4/6 inhibitor, which may help in controlling the growth of cancer cells. This medication is typically prescribed as part of a broader treatment plan, often in combination with other therapies.

Common effects of VERZENIO 100 MG tablets may include fatigue, nausea, and diarrhea. Some individuals might experience changes in their blood cell counts or gastrointestinal issues. It's important to discuss any persistent or severe effects with a healthcare provider.

VERZENIO 100 MG tablets should be handled with care, following the guidance of a healthcare professional. This medication may not be suitable for everyone, particularly those with certain pre-existing conditions. Regular monitoring and follow-up are often recommended during treatment.

VERZENIO 100 MG tablets may interact with other medications, including those that affect liver enzymes. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect how this medication works.